Dr Reddy’s launches Bosutinib tablets in US market

· thehindubusinessline.com

Dr. Reddy’s launches Bosutinib tablets in the US, enhancing its oncology portfolio through collaboration with MSN Laboratories.

Dr Reddy’s Laboratories launched Bosutinib tablets, a generic equivalent of Bosulif, in the US, expanding its oncology portfolio.

Hyderabad-based Dr. Reddy?...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI